Telescope Innovations Reports Significant Milestones and Financial Results of Fiscal Year 2025
Vancouver, British Columbia--(Newsfile Corp. - December 23, 2025) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope Innovations", "Telescope", or the "Company"), a developer of intelligent automation and advanced chemical manufacturing technologies, reports financial results for the fiscal year ended August 31, 2025. The Company generated revenues of $5.8 million during this period, with an Adjusted EBITDA loss of $402K (Figure 1). Telescope continues
Technology, Chemical, Pharmaceuticals, Psychedelics
2025-12-23 8:00 PM EST | Telescope Innovations Corp.
Entheon Announces Letter of Intent with Nutravisor Inc.
Vancouver, British Columbia--(Newsfile Corp. - December 22, 2025) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU) ("Entheon" or the "Company") is pleased to announce that it has entered into a binding Letter of Intent (the "LOI") dated December 18, 2025, with Nutravisor Inc. ("Nutravisor") whereby Entheon will acquire all of the issued and outstanding common shares of Nutravisor (the "Proposed Transaction"). Upon completion of the Proposed T
Biotechnology, Cannabis, Psychedelics, Cannabis Ancillary Service Provider
2025-12-22 9:30 AM EST | Entheon Biomedical Corp.
Steep Hill Provides Update on Transaction with Good Purpose Investments
Toronto, Ontario--(Newsfile Corp. - December 19, 2025) - Steep Hill Inc. (CSE: STPH) ("Steep Hill" or the "Company") is pleased to provide an update on its ongoing transaction with Good Purpose Investments Inc. ("Good Purpose"). Good Purpose is a privately held British Columbia corporation that operates a business engaged in the manufacturing, marketing, and distribution of textiles made from recycled plastics under the trade name "Waste2Wear." Through its subs
Retail, Cannabis, Psychedelics, Cannabis Manufacturer
2025-12-19 5:30 PM EST | Steep Hill Inc.
Optimi Health Announces Appointment of New Director
Vancouver, British Columbia--(Newsfile Corp. - December 18, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a Canadian GMP-compliant manufacturer of MDMA and psilocybin, is pleased to announce the appointment of Mr. Jason Mosberian as a director of the Company, effective immediately (the "Appointment"). Mr. Mosberian graduated from the Sauder School of Business and earned his CPA designation in 2011 working in audit in
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-12-18 7:00 AM EST | Optimi Health Corp.
Quantum BioPharma Announces Closing of Private Placement & Provides Corporate Update
Toronto, Ontario--(Newsfile Corp. - December 10, 2025) - Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FSE: 0K91) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development, is pleased to announce that, further to its news release o
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-12-10 8:00 PM EST | Quantum BioPharma Ltd.
Telescope Innovations Installs Korea's First Self-Driving Lab for Pharma R&D and Education
HIGHLIGHTS Telescope Innovations' installation of Korea's first Self-Driving Lab for pharmaceutical research completed just three weeks after contract signing Project facilitated by collaboration with the Acceleration Consortium (AC) and supported on site by two-time Chemistry Nobel Laureate Prof. Barry Sharpless Successful SDL delivery demonstrates Telescope's growing commercial momentum, positioning Telescope and the AC to expand SDL adoption across phar
Technology, Chemical, Pharmaceuticals, Psychedelics
2025-12-09 8:00 AM EST | Telescope Innovations Corp.
Numinus Wellness Provides Corporate Update
Vancouver, British Columbia--(Newsfile Corp. - December 1, 2025) - Numinus Wellness Inc. (TSX: NUMI) (OTCQX: NUMIF) ("Numinus" or the "Company"), a mental health care company focused on innovative behavioral health treatments with a focus on safe, evidence-based psychedelic-assisted therapies, is providing a corporate update. Change of auditors On October 10, 2025, the Company announced that Davidson & Company LLP ("Davidson") had resigned as the Company's i
2025-12-01 5:00 PM EST | Numinus Wellness Inc.
Red Light Holland Reports Second Quarter 2026 Results and Provides Corporate Update
Toronto, Ontario--(Newsfile Corp. - December 1, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based corporation engaged in the production, growth, and sale of functional mushrooms, mushroom home grow kits in North America and Europe, and a premium brand of psilocybin truffles to the legal recreational market within the Netherlands, in compliance with all applicable laws, announces its financial and operat
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2025-12-01 4:30 PM EST | Red Light Holland Corp.
Psyched Wellness Launches Calmer, a 2x Version of Calm and an Enhanced Flavour Profile for Calm
Toronto, Ontario--(Newsfile Corp. - November 27, 2025) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) (the "Company" or "Psyched"), a life sciences company specializing in the production and distribution of dietary supplements derived from the Amanita Muscaria mushroom, is pleased to announce the launch of Calmer, a new product offering that delivers twice the potency of its flagship product, Calm. The Company has also enhanced the flavour profile of Calm in
Cannabis, Health, Psychedelics, Cannabis Manufacturer
2025-11-27 7:30 AM EST | Psyched Wellness Ltd.
Optimi Health to Supply MDMA to MAPS Israel's Clinical Trial for Trauma-Related PTSD
Vancouver, British Columbia--(Newsfile Corp. - November 26, 2025) - Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FSE: 8BN) ("Optimi" or the "Company"), a Canadian manufacturer of pharmaceutical-grade psychedelics, including MDMA and naturally derived psilocybin, has been selected to supply the MDMA capsules for MAPS Israel's Healing October 7th project, which includes a clinical trial for Post-Traumatic Stress Disorder (PTSD) that has received formal approval from the Israeli
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-11-26 7:00 AM EST | Optimi Health Corp.
Red Light Holland's FDA-Compliant, DEA-Registered Partner Irvine Labs Receives Second, Larger 5kg Psilocybin Shipment via USA Controlled Substances Import Permit
Toronto, Ontario--(Newsfile Corp. - November 19, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based corporation engaged in the production, growth, and sale of functional mushrooms and mushroom home grow kits in North America and Europe, as well as a premium brand of psilocybin truffles in the legal, recreational market within the Netherlands, in compliance with all applicable laws is excited to announce that it has, f
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2025-11-19 7:45 AM EST | Red Light Holland Corp.
Telescope Innovations to Deliver First Self-Driving Lab for Korea's Largest Biopharma Manufacturers Association
HIGHLIGHTS This installation for Korea's largest biopharma association represents the first Self-Driving Lab ("SDL") for drug development to be deployed in Korea Partnership supports Korea's transition toward automated and digital R&D SDL automates continuous experimental optimization using robotics, analytics, and AI SDLs show expanding commercial relevance across pharma, minerals, energy, agriculture, and chemical
Technology, Chemical, Pharmaceuticals, Psychedelics
2025-11-17 8:00 AM EST | Telescope Innovations Corp.
Steep Hill Announces Amalgamation Agreement with Good Purpose Investments
Toronto, Ontario--(Newsfile Corp. - November 13, 2025) - Steep Hill Inc. (CSE: STPH) ("Steep Hill" or the "Company") is pleased to announce that it has entered into an amalgamation agreement (the "Amalgamation Agreement") dated effective November 12, 2025, with Good Purpose Investments Inc. ("Good Purpose") and 1561117 B.C. Ltd. ("Subco"), a wholly owned subsidiary of the Company, pursuant to which the Company will, by way of a three-cornered amalgama
Retail, Cannabis, Psychedelics, Cannabis Manufacturer
2025-11-13 10:19 AM EST | Steep Hill Inc.
Red Light Holland's Wholly Owned Subsidiary Happy Caps Expands Safeway Partnership to 123 Stores Across the U.S. Pacific Northwest, in Time for American Thanksgiving
Toronto, Ontario--(Newsfile Corp. - November 11, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), a company engaged in the production, growth, and sale of functional mushrooms and mushroom home grow kits in North America and Europe, is pleased to announce a major U.S. retail expansion milestone for its wholly owned subsidiary, 4316747 Nova Scotia Limited o/a Happy Caps Mushroom Farm ("Happy Caps") with Albertso
Cannabis, Health, Psychedelics, Cannabis Ancillary Service Provider
2025-11-11 8:39 AM EST | Red Light Holland Corp.
Neural's Portfolio Company Hanf.com Expands Retail Footprint to Northern Germany with Two New Stores in Bielefeld and Herford
Toronto, Ontario--(Newsfile Corp. - November 6, 2025) - Neural Therapeutics Inc. (CSE: NURL) (FSE: HANF) ("Neural" or the "Company"), an ethnobotanical drug discovery company focused on developing therapeutic solutions for mental health conditions related to substance use disorders, together with its portfolio company CWE European Holdings Inc. ("CWE"), operating as Hanf.com, in which it owns 30.75% int
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-11-06 8:46 AM EST | Neural Therapeutics Inc.
Telescope Innovations Conditionally Approved for up to $3.36 M in Government Funding to Advance Lithium Processing Technology
Vancouver, British Columbia--(Newsfile Corp. - November 4, 2025) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) ("Telescope Innovations", "Telescope", or the "Company") is a leader in providing intelligent automation platforms and services that accelerate chemical process development. The Company is pleased to announce that two Government of Canada funding streams totalling up to CAD $3.36 M have been formally or conditionally awarded to Telescope to support th
Technology, Chemical, Pharmaceuticals, Psychedelics
2025-11-04 11:00 AM EST | Telescope Innovations Corp.
PharmaDrug Announces Debt Restructuring
Toronto, Ontario--(Newsfile Corp. - October 31, 2025) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of natural medicines is pleased to announce that it has agreed to issue $445,686 principal amount of secured convertible debentures to two current holders of the Company's secured convertible debentures that were past their maturity date. Each Debe
Biotechnology, Cannabis, Psychedelics, Cannabis Manufacturer
2025-10-31 8:58 AM EDT | PharmaDrug Inc.
PharmaDrug Signs Definitive Agreement to Acquire Equity Interest in Canurta Inc
Toronto, Ontario--(Newsfile Corp. - October 30, 2025) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) ("PharmaDrug" or the "Company"), a specialty pharmaceutical company focused on the research, development and commercialization of natural medicines is pleased to announce that it has executed a definitive securities exchange agreement (the "Definitive Agreement") with Canurta Limited Partnership ("Canurta") and each of the limited partners of Canurta, the parent en
Biotechnology, Cannabis, Psychedelics, Cannabis Manufacturer
2025-10-30 9:00 AM EDT | PharmaDrug Inc.
Quantum BioPharma Ltd. Announces Corporate Updates
Toronto, Ontario--(Newsfile Corp. - October 29, 2025) - Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FSE: 0K91) (Upstream: QNTM) ("Quantum BioPharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol misuse disorders with drug candidates in different stages of development, today announces, as approved by the shareh
Biotechnology, Pharmaceuticals, Health, Psychedelics
2025-10-29 9:00 PM EDT | Quantum BioPharma Ltd.
Telescope Announces Debt Settlement Transaction
Vancouver, British Columbia--(Newsfile Corp. - October 23, 2025) - Telescope Innovations Corp. (CSE: TELI) (OTCQB: TELIF) (FSE: J4U) (the "Company"), a leading developer of advanced technologies and services for the global pharmaceutical and high-value chemical industries, is pleased to announce that it has entered into agreements to settle certain outstanding indebtedness through the issuance of 689,654 common shares (each, a "Share") of the Company (the "Debt Settlement"). Purs
Technology, Chemical, Pharmaceuticals, Psychedelics
2025-10-23 2:16 PM EDT | Telescope Innovations Corp.